Growth at a reasonable price, or GARP, is a strategy that sits between pure growth investing and traditional value investing. The goal is straightforward: find companies that are growing their earnings and revenues at an above-average rate, but that haven’t yet become so expensive that the market has priced in all future potential. By screening for stocks with strong growth, solid profitability, decent financial health, and a valuation that isn’t excessive, investors can aim for the upside of growth while avoiding the risk of paying too much for it. This approach prioritizes companies that offer a blend of momentum and discipline, making them potential candidates for a long-term buy-and-hold portfolio.
IMAX CORP (NYSE:IMAX) stands out as a candidate that fits this mold well. According to the ChartMill fundamental analysis report, the company earns a solid overall fundamental rating of 6 out of 10, with particularly strong scores in growth and profitability that support the GARP thesis.
Growth: The Core Engine
For any GARP-focused investor, growth is the primary non-negotiable. IMAX delivers here. The company has posted an impressive 59.14% year-over-year increase in Earnings Per Share (EPS) and a 174.00% average annual EPS growth rate over a multiyear period. Revenue growth is also strong, coming in at 12.56% over the last year with a multiyear average of 24.53% .
These aren’t just backward-looking numbers. Looking forward, analysts expect EPS to grow at an average of 15.33% per year over the next few years, while revenue is projected to climb at a 7.29% annual rate. While the pace of expansion is expected to moderate from the recent blistering clip, it still represents strong above-market growth. In the screening methodology used, IMAX earned a ChartMill Growth Rating of 7 out of 10, placing it ahead of a large portion of its industry peers.
Valuation: Paying a Fair Price
The "reasonable price" part of GARP is just as critical. High growth is attractive, but if the stock is priced for perfection, it becomes a risky bet. On the surface, IMAX’s trailing Price/Earnings (P/E) ratio of 30.39 looks elevated compared to the broader market. However, context matters.
- Relative to the industry: IMAX’s P/E of 30.39 is actually cheaper than 83.54% of its peers in the Entertainment industry (which carry a much higher average P/E of 37.16).
- Forward earnings: The Price/Forward Earnings ratio of 22.58 is more palatable and suggests that near-term profits will help justify the current price.
- PEG ratio: The PEG (Price/Earnings to Growth) ratio, which adjusts the P/E for the expected growth rate, indicates a "correct valuation." This is a key metric for GARP, confirming that the growth is not yet fully priced in.
- Other multiples: The Enterprise Value to EBITDA and Price/Free Cash Flow ratios are also cheaper than roughly 72-76% of industry competitors.
IMAX received a ChartMill Valuation Rating of 5 out of 10, which is considered neutral. While not a deep value play, this rating signals that the stock isn’t in overvalued territory either—exactly the middle ground GARP investors are looking for.
Profitability and Health: The Supporting Pillars
A growth stock that lacks profitability or carries excessive debt is a red flag, no matter how fast it is expanding. IMAX scores well on both fronts.
Profitability (Rating: 7 out of 10) : The company is profitable, with a positive operating cash flow. Its Return on Equity (ROE) stands at 10.96%, and its Return on Invested Capital (ROIC) is 9.37%—both metrics comfortably outperform over 84% of the industry. The operating margin of 21.62% is in the top decile of competitors (outperforming 92.41% ), and it has been growing in recent years. This suggests IMAX is not just growing top-line revenue but also running an efficient, well-managed operation.
Health (Rating: 6 out of 10) : The balance sheet is in decent shape. IMAX has an Altman-Z score of 3.26, which indicates low bankruptcy risk and is better than 84.81% of its peers. The Debt to Free Cash Flow ratio sits at a manageable 2.63, meaning it would take less than three years of free cash flow to pay off all debt. The Current Ratio of 1.91 provides a solid liquidity buffer for short-term obligations. One caveat for growth-oriented investors: IMAX does not pay a dividend, so total returns here rely entirely on price appreciation and earnings growth.
Putting It All Together
When you combine the strong historical and forward growth with a valuation that is neutral-to-cheap compared to its industry, IMAX fits the profile of an affordable growth stock. It’s growing fast, profitable, and reasonably priced relative to its sector—qualities that the Affordable Growth screening methodology is specifically designed to capture.
For investors looking for other stocks that meet similar criteria—combining strong growth ratings with decent valuation and solid financial health—you can explore the full list of candidates using the ChartMill Affordable Growth Screener. You can also examine IMAX’s complete fundamental data via the full fundamental analysis report.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always do your own research before making any investment decisions.
Read full article here »
View the Zacks #1 Rank List
IMAX Corp (NYSE:IMAX): A GARP Growth Stock at a Reasonable Price
Growth at a reasonable price, or GARP, is a strategy that sits between pure growth investing and traditional value investing. The goal is straightforward: find companies that are growing their earnings and revenues at an above-average rate, but that haven’t yet become so expensive that the market has priced in all future potential. By screening for stocks with strong growth, solid profitability, decent financial health, and a valuation that isn’t excessive, investors can aim for the upside of growth while avoiding the risk of paying too much for it. This approach prioritizes companies that offer a blend of momentum and discipline, making them potential candidates for a long-term buy-and-hold portfolio.
IMAX CORP (NYSE:IMAX) stands out as a candidate that fits this mold well. According to the ChartMill fundamental analysis report, the company earns a solid overall fundamental rating of 6 out of 10, with particularly strong scores in growth and profitability that support the GARP thesis.
Growth: The Core Engine
For any GARP-focused investor, growth is the primary non-negotiable. IMAX delivers here. The company has posted an impressive 59.14% year-over-year increase in Earnings Per Share (EPS) and a 174.00% average annual EPS growth rate over a multiyear period. Revenue growth is also strong, coming in at 12.56% over the last year with a multiyear average of 24.53% .
These aren’t just backward-looking numbers. Looking forward, analysts expect EPS to grow at an average of 15.33% per year over the next few years, while revenue is projected to climb at a 7.29% annual rate. While the pace of expansion is expected to moderate from the recent blistering clip, it still represents strong above-market growth. In the screening methodology used, IMAX earned a ChartMill Growth Rating of 7 out of 10, placing it ahead of a large portion of its industry peers.
Valuation: Paying a Fair Price
The "reasonable price" part of GARP is just as critical. High growth is attractive, but if the stock is priced for perfection, it becomes a risky bet. On the surface, IMAX’s trailing Price/Earnings (P/E) ratio of 30.39 looks elevated compared to the broader market. However, context matters.
IMAX received a ChartMill Valuation Rating of 5 out of 10, which is considered neutral. While not a deep value play, this rating signals that the stock isn’t in overvalued territory either—exactly the middle ground GARP investors are looking for.
Profitability and Health: The Supporting Pillars
A growth stock that lacks profitability or carries excessive debt is a red flag, no matter how fast it is expanding. IMAX scores well on both fronts.
Profitability (Rating: 7 out of 10) : The company is profitable, with a positive operating cash flow. Its Return on Equity (ROE) stands at 10.96%, and its Return on Invested Capital (ROIC) is 9.37%—both metrics comfortably outperform over 84% of the industry. The operating margin of 21.62% is in the top decile of competitors (outperforming 92.41% ), and it has been growing in recent years. This suggests IMAX is not just growing top-line revenue but also running an efficient, well-managed operation.
Health (Rating: 6 out of 10) : The balance sheet is in decent shape. IMAX has an Altman-Z score of 3.26, which indicates low bankruptcy risk and is better than 84.81% of its peers. The Debt to Free Cash Flow ratio sits at a manageable 2.63, meaning it would take less than three years of free cash flow to pay off all debt. The Current Ratio of 1.91 provides a solid liquidity buffer for short-term obligations. One caveat for growth-oriented investors: IMAX does not pay a dividend, so total returns here rely entirely on price appreciation and earnings growth.
Putting It All Together
When you combine the strong historical and forward growth with a valuation that is neutral-to-cheap compared to its industry, IMAX fits the profile of an affordable growth stock. It’s growing fast, profitable, and reasonably priced relative to its sector—qualities that the Affordable Growth screening methodology is specifically designed to capture.
For investors looking for other stocks that meet similar criteria—combining strong growth ratings with decent valuation and solid financial health—you can explore the full list of candidates using the ChartMill Affordable Growth Screener. You can also examine IMAX’s complete fundamental data via the full fundamental analysis report.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always do your own research before making any investment decisions.
Read full article here »